Trial Profile
Clinical study of NPH29 in patients with skin hyperpigmentation
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jul 2015
Price :
$35
*
At a glance
- Drugs NPH 29 (Primary)
- Indications Hyperpigmentation
- Focus Therapeutic Use
- Sponsors nPharmakon LLC
- 08 Jul 2015 New trial record
- 01 Jul 2015 Results published in an nPharmakon media release.